Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Basic Science Investigation

  • <sup>18</sup>F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical Models
    You have access
    18F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical Models
    Thuc M. Le, Hailey R. Lee, Evan R. Abt, Khalid Rashid, Amanda L. Creech, Keke Liang, Jing Cui, Arthur Cho, Liu Wei, Amanda Labora, Charlotte Chan, Eric Sanchez, Kriti Kriti, Daniel Karin, Luyi Li, Nanping Wu, Christine Mona, Giuseppe Carlucci, Willy Hugo, Ting-Ting Wu, Timothy R. Donahue, Johannes Czernin and Caius G. Radu
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 117-123; DOI: https://doi.org/10.2967/jnumed.122.264121
  • <sup>18</sup>F-Fluciclovine PET Imaging of Glutaminase Inhibition in Breast Cancer Models
    You have access
    18F-Fluciclovine PET Imaging of Glutaminase Inhibition in Breast Cancer Models
    Rong Zhou, Hoon Choi, Jianbo Cao, Austin Pantel, Mamta Gupta, Hsiaoju S. Lee and David Mankoff
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 131-136; DOI: https://doi.org/10.2967/jnumed.122.264152
  • Evaluation of (<em>rac</em>)-, (<em>R</em>)-, and (<em>S</em>)-<sup>18</sup>F-OF-NB1 for Imaging GluN2B Subunit–Containing <em>N</em>-Methyl-<span class="sc">d</span>-Aspartate Receptors in Nonhuman Primates
    You have access
    Evaluation of (rac)-, (R)-, and (S)-18F-OF-NB1 for Imaging GluN2B Subunit–Containing N-Methyl-d-Aspartate Receptors in Nonhuman Primates
    Hazem Ahmed, Ming-Qiang Zheng, Kelly Smart, Hanyi Fang, Li Zhang, Paul R. Emery, Hong Gao, Jim Ropchan, Achi Haider, Gilles Tamagnan, Richard E. Carson, Simon M. Ametamey and Yiyun Huang
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1912-1918; DOI: https://doi.org/10.2967/jnumed.122.263977
  • Safety and Efficacy of <sup>166</sup>Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study
    You have access
    Safety and Efficacy of 166Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study
    Margot T.M. Reinders, Karel J. van Erpecum, Maarten L.J. Smits, Arthur J.A.T. Braat, Joep de Bruijne, Rutger Bruijnen, Dave Sprengers, Robert A. de Man, Erik Vegt, Jan N.M. IJzermans, Adriaan Moelker and Marnix G.E.H. Lam
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1891-1898; DOI: https://doi.org/10.2967/jnumed.122.263823
  • A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake
    You have access
    A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake
    Andrea Galbiati, Aureliano Zana, Matilde Bocci, Jacopo Millul, Abdullah Elsayed, Jacqueline Mock, Dario Neri and Samuele Cazzamalli
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1852-1858; DOI: https://doi.org/10.2967/jnumed.122.264036
  • Fully Automated, Semantic Segmentation of Whole-Body <sup>18</sup>F-FDG PET/CT Images Based on Data-Centric Artificial Intelligence
    You have access
    Fully Automated, Semantic Segmentation of Whole-Body 18F-FDG PET/CT Images Based on Data-Centric Artificial Intelligence
    Lalith Kumar Shiyam Sundar, Josef Yu, Otto Muzik, Oana C. Kulterer, Barbara Fueger, Daria Kifjak, Thomas Nakuz, Hyung Min Shin, Annika Katharina Sima, Daniela Kitzmantl, Ramsey D. Badawi, Lorenzo Nardo, Simon R. Cherry, Benjamin A. Spencer, Marcus Hacker and Thomas Beyer
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1941-1948; DOI: https://doi.org/10.2967/jnumed.122.264063
  • Using <sup>68</sup>Ga-PSMA-11 PET/CT for Therapy Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer: Application of EAU/EANM Recommendations in Clinical Practice
    You have access
    Using 68Ga-PSMA-11 PET/CT for Therapy Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer: Application of EAU/EANM Recommendations in Clinical Practice
    Chloé S. Denis, François Cousin, Bram De Laere, Roland Hustinx, Brieuc R. Sautois and Nadia Withofs
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1815-1821; DOI: https://doi.org/10.2967/jnumed.121.263611
  • Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model
    You have access
    Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model
    Ali Pirasteh, Sarvesh Periyasamy, Jennifer Jean Meudt, Yongjun Liu, Laura M. Lee, Kyle M. Schachtschneider, Lawrence B. Schook, Ron C. Gaba, Lu Mao, Adnan Said, Alan Blair McMillan, Paul F. Laeseke and Dhanansayan Shanmuganayagam
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1956-1961; DOI: https://doi.org/10.2967/jnumed.121.263736
  • <sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in Mice
    You have access
    89Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted 227Th-Conjugate Therapy in Mice
    Linda N. Broer, Daan G. Knapen, Frans V. Suurs, Ingrid Moen, Danique Giesen, Stijn J.H. Waaijer, Baard Indrevoll, Christine Ellingsen, Alexander Kristian, Alan S. Cuthbertson, Derk-Jan A. de Groot, Patricia E. Cole, Elisabeth G.E. de Vries, Urs B. Hagemann and Marjolijn N. Lub-de Hooge
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1715-1721; DOI: https://doi.org/10.2967/jnumed.121.263079
  • Synthesis and Preclinical Evaluation of <sup>18</sup>F-Labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation
    You have access
    Synthesis and Preclinical Evaluation of 18F-Labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation
    Miho Shukuri, Aya Mawatari, Shuhei Takatani, Tsuyoshi Tahara, Michiko Inoue, Wakiko Arakaki, Masahiro Ohno, Hisashi Doi and Hirotaka Onoe
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1761-1767; DOI: https://doi.org/10.2967/jnumed.121.263713

Pages

  • Previous
  • Next
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 45
SNMMI

© 2025 SNMMI

Powered by HighWire